13,895
Total Claims
$2.0M
Drug Cost
2,234
Beneficiaries
$885
Cost/Patient
Peer Comparison vs. 4,479 Interventional Cardiology providers
-16%
Cost per patient vs peers
$885 vs $1,054 avg
-19%
Brand preference vs peers
10.6% vs 13.1% avg
Brand vs Generic
89% generic
Brand: 1,472 claims · $1.7M
Generic: 12,423 claims · $265K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 1,031 | $1.4M |
| Rivaroxaban | 162 | $213K |
| Evolocumab | 39 | $52K |
| Ticagrelor | 35 | $29K |
| Rosuvastatin Calcium | 1,133 | $23K |
| Sacubitril/Valsartan | 20 | $21K |
| Clopidogrel Bisulfate | 1,046 | $17K |
| Metoprolol Succinate | 1,010 | $16K |
| Clonidine | 36 | $12K |
| Atorvastatin Calcium | 961 | $12K |
| Diltiazem Hcl | 314 | $12K |
| Valsartan/Hydrochlorothiazide | 114 | $9,260 |
| Ranolazine | 82 | $8,814 |
| Losartan Potassium | 571 | $7,368 |
| Olmesartan Medoxomil | 363 | $7,263 |
Prescribing Profile
80
Unique Drugs
$1.6M
Patient Profile
77
Avg Age
47%
Female
1.52
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About